Lubiprostone helps to enhance intestinal permeability in humans. Hence it may inhibit leaky gut syndrome.[1]
Lubiprostone is a bicyclic fatty acid that activates ClC-2 and CFTR chloride channels.
Lubiprostone is a bicyclic fatty acid that activates ClC-2 and CFTR chloride channels. Some reports suggest that lubiprostone opens CFTR or both CFTR and ClC-2 through interactions with the prostaglandin receptor EP4. Lubiprostone is used clinically to treat idiopathic chronic constipation and irritible bowel syndrome.
Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers
Kato T, et al.
Testing, 12(4), e0175626-e0175626 (2017)
Questions
Reviews
★★★★★ No rating value
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.